A page from the COVID therapy playbook: Unleashing a flood of neutralizing antibodies against HIV
For more than 40 years a goal that too often has proved elusive is a pharmaceutical defeat of the human immunodeficiency virus—HIV. And the thrust in recent years has emphasized bringing newer, stealthier weapons to the ...